To validate this hypothesis, in the current study we determined the impact of removal of the glucocorticoid function in APOE knockout mice on the outcome of two inflammation-associated pathologies, endotoxemia and atherosclerosis. The gene discussed is APOE; the disease is atherosclerosis.